March 8, 2021
Authored and Edited by Shannon M. Patrick; Kara A. Specht; Elizabeth D. Ferrill
In Rain Computing, Inc. v. Samsung Electronics Co., Ltd., the Federal Circuit reversed the district court’s determination that “user identification module” was not indefinite.
The Federal Circuit first analyzed whether “user identification module” is a means-plus-function term. For terms not including “means for” language, the term will only be construed as means-plus-function if it recites a function without sufficient structure for performing the function. The Federal Circuit found the term was a means-plus-function term because Rain failed to identify claim language that provided the structure for performing the claimed function and that the term itself “merely describe[ed] the function of the module: to identify a user.” Slip op. at 5.
The analysis next turned to identifying the function and corresponding structure in the specification, consistent with procedures for construing means-plus-function terms. Under relevant precedent, “[w]here a general-purpose computer is the corresponding structure and it is not capable of performing the controlling access function absent specialized software,” the patent must disclose an algorithm for performing the claimed function. Id. at 9. Because no algorithm could be found, the Federal Circuit held that the term “user identification module” lacked sufficient structure, rendering the claims indefinite.
claim construction, means-plus-function claim, United States Court of Appeals for the Federal Circuit (CAFC)
Copyright © 2021 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.